Treatment of dry eyes in Sjögren's syndrome: the role of autologous blood serum

Bibliography

• de Paiva CS, Hwang CS, Pitcher JD III, et al. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) 2010;49:246-58
   PubMed Web of Science ®Google Scholar
• De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci 2007;48:2553-60
   PubMed Web of Science ®Google Scholar
• Luo L, Li DQ, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293-301
   PubMed Web of Science ®Google Scholar
• Pflugfelder S, Huang A, Feuer W, et al. Conjunctival cytologic features of primary Sjögren's syndrome. Ophthalmology 1990;97(8):985-91
   Google Scholar
• Tsubota K, Toda I, Yagi Y, et al. Three different types of dry eye syndrome. Cornea 1994;13(3):202-9
   PubMed Web of Science ®Google Scholar
• Homma M, Sugai S, Tojo T, et al. SS dry eye and non-SS dry eye: what are the differences? In: Homma M, Sugai S, Tojo T, et al. editors. Sjögren's syndrome. Kugler; Amsterdam: 1994. p. 27-31
   Google Scholar
• Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88(11):1467-74
   PubMed Web of Science ®Google Scholar
• Whaley K, Williamson J, Chisholm D, et al. Sjögren' s syndrome. I. Sicca components. Q J Med 1973;42(166):279-304
   Google Scholar
• Liu Z, Pflugfelder SC. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology 1999;106(5):939-43
   PubMed Web of Science ®Google Scholar
• Balaram M, Schaumberg DA, Dana MR. Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol 2001;131(1):30-6
   PubMed Web of Science ®Google Scholar
• Ali Z, Insler MS. A comparison of therapeutic bandage lenses, tarsorrhaphy, antibiotic and hypertonic saline on corneal epithelial wound healing. Ann Ophthalmol 1986;18(1):22-4
   Google Scholar
• Panda A, Pushker N, Bageshwar LM. Lateral tarsorrhaphy: is it preferable to patching? Cornea 1999;18(3):299-301
   Google Scholar
• Pfister RR, Burnstein N. The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study. Invest Ophthalmol Vis Sci 1976;15(4):246-59
   Google Scholar
• Gunduz K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome. Acta Ophthalmol (Copenh) 1994;72(4):438-42
   PubMed Web of Science ®Google Scholar
• Yavuz S, Asfuroğlu E, Bicakcigil M, Toker E. Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome. Rheumatol Int 2011;31(8):1045-9
   Google Scholar
• Brignole-Baudouin F, Baudouin C, Aragona P, et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol 2011;89(7):e591-7
   PubMed Web of Science ®Google Scholar
• Worda C, Nepp J, Huber JC, Sator MO. Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas 2001;37(3):209-12
   PubMed Web of Science ®Google Scholar
• Tsifetaki N, Kitsos G, Paschides CA, et al. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study. Ann Rheum Dis 2003;62(12):1204-7
   PubMed Web of Science ®Google Scholar
• Braga MA, Tarzia O, Bergamaschi CC, et al. Comparison of the effects of pilocarpine and cevimeline on salivary flow. Int J Dent Hyg 2009;7(2):126-30
   Google Scholar
• Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999;83(4):399-402
   PubMed Web of Science ®Google Scholar
• Tan DT, Ficker LA, Buckley RJ. Limbal transplantation. Ophthalmology 1996;103(1):29-36
   PubMed Web of Science ®Google Scholar
• Gordon JF, Johnson P, Musch DC; Chiron Vision Fibronectin Study Group. Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Am J Ophthalmol 1995;119(3):281-7
   Google Scholar
• Imanishi J, Kamiyama K, Iguchi I, et al. Growth factors: importance in wound healing and maintenance of transparency of the corneas. Prog Retinal Eye Res 2000;19(1):113-29
   PubMed Web of Science ®Google Scholar
• Chikama T, Fukuda K, Morigishe N, et al. Treatment of neurotrophic keratopathy with substance-P derived peptide (FGLM) and insulin-like growth factor I. Lancet 1998;351(9118):1783-4
   PubMed Web of Science ®Google Scholar
• Ralph RA. Tetracyclines and the treatment of corneal stromal ulceration. Cornea 2000;19(3):274-7
   Google Scholar
• Pellegrini G, Traverso CE, Franzi AT, et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997;349(9057):990-3
   PubMed Web of Science ®Google Scholar
• The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop. Ocul Surf 2007;5(2):93-107
   PubMed Web of Science ®Google Scholar
• Chiou AG, Florakis GJ, Kazim M. Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction. Surv Ophthalmol 1998;43(1):19-46
   Google Scholar
• Geerling G, Daniels JT, Dart JK, et al. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalm Vis Sci 2001;42(5):948-56
   PubMed Web of Science ®Google Scholar
• Ubels JL, Williams KK, Lopez Bernal D, Edelhauser HF. Evaluation of effects of a physiologic artificial tear on the corneal epithelial barrier: electrical resistance and carboxyfluorescein permeability. Adv Exp Med Biol 1994;350:441-52
   PubMedGoogle Scholar
• Poon AC, Geerling G, Dart JKG, et al. Autologous serum eye drops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001;85(10):1188-97
   Google Scholar
• Pasternak AS, Miller WM. First-order toxicity assays for eye irritation using cell lines: parameters that affect in vitro evaluation. Fundam Appl Toxicol 1995;25(2):253-63
   Google Scholar
• Wang XM, Terasaki PI, Rankin GW Jr, et al. A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol 1993;37(4):264-70
   Google Scholar
• Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27(4):459-61
   PubMedGoogle Scholar
• Autologous serum eye drops: important patient information. hospitals & science website. document INF/PTI/PR/009/01. Available from: http://hospital.blood.co.uk/library/pdf/eye_drops.pdf [Last accessed 6 February 2013]
   Google Scholar
• Flanagan P. Autologous serum eye drops. Blood Issues 2004;11:1-4
   Google Scholar
• Wilson S. Lacrimal gland epidermal growth factor production and the ocular surface. Am J Ophthalmol 1991;111(6):763-5
   Google Scholar
• Ubels J, Loley K, Rismondo V. Retinol secretion by the lacrimal gland. Invest Ophthalmol Vis Sci 1986;27(8):1261-8
   Google Scholar
• Ohashi Y, Motokura M, Kinoshita Y, et al. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci 1989;30(8):1879-82
   Google Scholar
• Van Setten G, Viinikka L, Tervo T. Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol 1989;227(2):184-7
   Google Scholar
• van Setten G, Macauley S, Humphresy-Beher M, et al. Detection of transforming growth factor-alpha mRNA and protein in rat lacrimal glands and characterization of transforming growth-alpha in human tears. Invest Ophthalmol Vis Sci 1996;37(1):166-73
   Google Scholar
• van Settten G, Tervo T, Tervo K, Tarkkanen A. Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations. Acta Ophthalmol 1992;202:54-9
   Google Scholar
• Scardovi CV, De Felice GP, Gazzaniga A. Epidermal growth factor in the topical treatment of traumatic corneal ulcers. Ophthalmologica 1993;206(3):119-24
   Google Scholar
• Pastor JC, Calonge M. Epidermal growth factor and corneal wound healing: a multicenter study. Cornea 1992;11(4):311-14
   Google Scholar
• Rodeck U, Jost M, Kari C, et al. EGF-R dependent regulation of keratinocyte survival. J Cell Sci 1997;110(Pt 2):113-21
   PubMedGoogle Scholar
• Fredj-Reygrobellet D, Plouet J, Delayre T, et al. Effects of aFGF and bFGF on wound healing in rabbit corneas. Curr Eye Res 1987;6(10):1205-9
   PubMed Web of Science ®Google Scholar
• Yamada N, Morishige N, Yanai R, et al. Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects. Cornea 2012;31(12):1408-13
   Google Scholar
• Berman MB. Collagenase inhibitors: rationale for their use in treating corneal ulceration. Int Ophthalmol Clin 1975;15(4):49-66
   Google Scholar
• Nishida T, Nakamura M, Ofuji K, et al. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol 1996;169(1):159-66
   PubMed Web of Science ®Google Scholar
• Bradley JC, Simoni J, Bradley RH, et al. Time and temperature-dependent stability of growth factor peptides in human autologous serum eye drops. Cornea 2009;28(2):200-5
   Google Scholar
• Wilson SE, Chen L, Mohan RR, et al. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res 1999;68(4):377-97
   PubMed Web of Science ®Google Scholar
• Kim WJ, Mohan RR, Mohan RR, Wilson SE. Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea. Invest Ophthalmol Vis Sci 1999;40(7):1364-72
   PubMed Web of Science ®Google Scholar
• Ebner S, You L, Voelcker HE, Kruze FE. Effect of autologous serum on the healing of non-infectious corneal ulcers and expression of growth factor receptors in the cornea. Ophthalmologe 2001;98:S27
   Google Scholar
• Nelson JD, Gordon JF. Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group. Am J Ophthalmol 1992;114(4):441-7
   Google Scholar
• Lopez BD, Ubels JL. Artificial tear composition and promotion of recovery of the damaged corneal epithelium. Cornea 1993;12(2):115-20
   Google Scholar
• Chung JH, Fagerholm P. Treatment of rabbit corneal alkali wounds with human epidermal growth factor. Cornea 1989;8(2):122-8
   Google Scholar
• Tseng SC, Zhang SH. Interaction between rose Bengal and different protein components. Cornea 1995;14(4):427-35
   Google Scholar
• Shimmura S, Ueno R, Matsumoto Y, et al. Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol 2003;87(10):1279-83
   PubMedGoogle Scholar
• Higuchi A, Ueno R, Shimmura S, et al. Albumin rescues ocular epithelial cells from cell death in dry eye. Curr Eye Res 2007;32(2):83-8
   PubMed Web of Science ®Google Scholar
• Unterlauft JD, Kohlhaas M, Kasper K, et al. The effect of albumin eye drops on ocular surface diseases [Program#/Poster#: 6305/D903]. ARVO 2009 Annual Meeting; 2009
   Google Scholar
• Higuchi A, Takahashi K, Hirashima M, et al. Controls oxidative stress in cornea. PLoS One 2010;5(3):e9911
   Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136(2):318-26
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol 2009;127(6):763-8
   PubMedGoogle Scholar
• Noble BA, Loh RSK, MacLennan S, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88(5):647-52
   PubMed Web of Science ®Google Scholar
• Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eye drops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005;139(2):242-6
   PubMed Web of Science ®Google Scholar
• Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999;83(4):390-5
   PubMed Web of Science ®Google Scholar
• Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol 2007;144(1):86-92
   PubMed Web of Science ®Google Scholar
• Tananuvat N, Daniell M, Sullivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001;20(8):802-6
   PubMed Web of Science ®Google Scholar
• Jover BA, Márques PJF, Márques K, et al. Effectiveness of 100% autologous serum drops in ocular surface disorders. Farm Hosp 2011;35(1):8-13
   Google Scholar
• Dalmon CA, Chandra NS, Jeng BH. Use of autologous serum eye drops for the treatment of ocular surface disease: first US experience in a large population as an insurance-covered benefit. Arch Ophthalmol 2012;130(12):1612-13
   Google Scholar
• Jeng BH, Dupps WJ Jr. Autologous serum 50% eye drops in the treatment of persistent corneal epithelial defects. Cornea 2009;28(10):1104-8
   PubMed Web of Science ®Google Scholar
• Ferreira de Souza R, Kruse FE, Seitz B. Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes. Klin Monbl Augenheilkd 2001;218(11):720-6; Article in German
   Google Scholar
• Tsubota K, Satake Y, Shimazaki J. Treatment of severe dry eye. Lancet 1996;348(3020):123
   Google Scholar
• Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthamol 1996;122(1):38-52
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111(6):1115-20
   PubMed Web of Science ®Google Scholar
• Matsuo H, Tomidokoro A, Tomita G, Araie M. Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb. Eye (Lond) 2005;19(1):23-8
   Google Scholar
• Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001;20(8):807-10
   Google Scholar
• Rocha EM, Pelegrino FS, de Paiva CS, et al. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 2000;25(10):1101-3
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003;31(7):579-83
   PubMed Web of Science ®Google Scholar
• Noda-Tsuruya T, Asano-Kato N, Toda I, Tsubota K. Autologous serum eye drops for dry eye after LASIK. J Refract Surg 2006;22(1):61-6
   PubMed Web of Science ®Google Scholar
• Toda I, Asano-Kato N, Hori-Komai Y, Tsubota K. Ocular surface treatment before laser in situ keratomileusis in patients with severe dry eye. J Refract Surg 2004;20(3):270-5
   Google Scholar
• López-García JS, Rivas L, García-Lozano I, Murube J. Autologous serum eye drops in the treatment of aniridic keratopathy. Ophthalmology 2008;115(2):262-7
   PubMed Web of Science ®Google Scholar
• López-García JS, García-Lozano I, Rivas L, Martínez-Garchitorena J. Use of autologous serum in ophthalmic practice. Arch Soc Esp Oftalmol 2007;82(1):9-20
   Google Scholar
• Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 2004;88(4):464-5
   PubMed Web of Science ®Google Scholar
• García Jiménez V, Veiga Villaverde B, Baamonde Arbaiza B, et al. The elaboration, use and evaluation of eye-drops with autologous serum in corneal lesions. Farm Hosp 2003;27(1):21-5; Article in Spanish
   Google Scholar
• Lee GA, Chen SX. Autologous serum in the management of recalcitrant dry eye syndrome. Clin Experiment Ophthalmol 2008;36(2):119-22
   Google Scholar
• Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999;106(10):1984-9
   PubMed Web of Science ®Google Scholar
• Hocson SI III, Lo KT, Lim-Bon-Siong R. Comparison of 20% autologous serum eye drops with unpreserved hypromellose in the treatment of aqueous-tear deficient dry-eye disease. Philipp J Ophthalmol 2007;32(1):18-24
   Google Scholar
• Liu L, Hartwig D, Harloff S, et al. An optimised protocol for the production of autologous serum eye drops. Graefes Arch Clin Exp Ophthalmol 2005;243(7):706-14
   Google Scholar
• MacLennan S. Comment in e-network forum of California Blood Bank Society (CBBS). Available from: www.cbbsweb.org/enf/2007/autol_eyedrops.html [Last accessed July 2012]
   Google Scholar
• Ziakas NG, Boboridis KG, Terzidou C, et al. Long-term follow up of autologous serum treatment for recurrent corneal erosions. Clin Experiment Ophthalmol 2010;38(7):683-7
   Google Scholar
• Young AL, Cheng AC, Ng HK, et al. The use of autologous serum tears in persistent corneal epithelial defects. Eye (Lond) 2004;18(6):609-14
   Google Scholar
• Partal A, Scott E. Low-cost protocol for the production of autologous serum eye drops by blood collection and processing centres for the treatment of ocular surface diseases. Transfus Med 2011;21(4):271-7
   PubMed Web of Science ®Google Scholar
• Nistor M, Nistor C. Autologous serum utilization in patients with lacrimal hyposecretion and persistent epithelial defects of cornea–clinical study. Oftalmologia 2005;49(3):30-3; Article in Romanian
   Google Scholar
• Leite SC, de Castro RS, Alves M, et al. Risk factors and characteristics of ocular complications, and efficiency of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant 2006;38(3):223-71
   Google Scholar
• Chiang C-C, Chen W-L, Lin J-M, Tsai Y-Y. Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect. Eye (Lond) 2009;23(2):290-3
   Google Scholar
• Kasper K, Godenschweger L, Hartwig D, et al. On the use of autologous serum eye drops in Germany: results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG). Ophthalmologe 2008;105(7):644-9; Article in German
   Google Scholar
• Welder JD, Bakhtiari P, Djalilian AR. Limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis. Case Rep Ophthalmol Med 2011;2011:576521
   Google Scholar
• McDonnell PH, Schanzlin DJ, Rao NA. Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol 1988;106(10):1423-5
   Google Scholar
• Salahuddin SZ, Palestine AG, Heck E, et al. Isolation of the human T-cell leukemia/lymphotropic virus type III from the cornea. Am J Ophthalmol 1986;101(2):149-52
   Google Scholar
• Fujikawa LS, Palestine AG, Nussenblatt RB, et al. Isolation of a T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet 1985;2(8454):529-30
   Google Scholar
• Eberle J, Habermann J, Gurtler LG. HIV-1 infection transmitted by serum droplets into the eye: a case report. AIDS 2000;14(2):206-7
   PubMed Web of Science ®Google Scholar
• Gioannini P, Sinicco A, Cariti G, et al. HIV infection acquired by a nurse. Eur J Epidemiol 1988;4(1):119-20
   Google Scholar
• Sauer R, Blüthner K, Seitz B. Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects. Ophthalmologe 2004;101(7):705-9; Article in German
   PubMed Web of Science ®Google Scholar
• Burstein NL. The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. Trans Ophthalmol Soc UK 1985;104(Pt 4):402-9
   PubMedGoogle Scholar
• Göbbels M, Spitznas M. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology 1992;99(6):873-8
   PubMed Web of Science ®Google Scholar
• Yokoi N, Komuro A, Nishida K, Kinoshita S. Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye [see comments]. Br J Ophthalmol 1997;81(7):533-6
   Google Scholar
• Aragona P, Papa V, Micali A, et al. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002;86(2):181-4
   PubMed Web of Science ®Google Scholar
• Gomes JA, Amankwah R, Powell-Richards A, Dua HS. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 2004;88(6):821-5
   PubMed Web of Science ®Google Scholar
• Mac Rae SM, Edelhauser HF, Hyndiuk RA, et al. The effects of sodium hyaluronate, chondroitin sulfate, and methylcellulose on the corneal endothelium and intraocular pressure. Am J Ophthalmol 1983;95(3):332-41
   Google Scholar
• Tanaka T, Inoue H, Kudo S, Ogawa T. Relationship between postoperative intraocular pressure elevation and residual sodium hyaluronate following phacoemulsification and aspiration. J Cataract Refract Surg 1997;23(2):284-8
   Google Scholar
• Schulze S, Sekundo W, Kroll P. Autologous serum versus hyaluronic acid eye drops for the treatment of corneal erosions after vitrectomy in diabetic patients. A prospective randomized study. Ophthalmologe 2005;102(9):863-8; Article in German
   Google Scholar
• Schrader S, Wedel T, Moll R, Geerling G. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Graefes Arch Clin Exp Ophthalmol 2006;244(10):1345-9
   Google Scholar
• Jones L, Senchyna M, Glasier MA, et al. Lysozyme and lipid deposition on silicone hydrogel contact lens materials. Eye Contact Lens 2003;29(1 Suppl):S75-9; discussion S83-4, S192-4
   PubMedGoogle Scholar